Calcium, Bioenergetics, and Parkinson’s Disease
Open accessThe DOI matches its Crossref record; 404 of the 407 references it cites were found in a registry or an index.
Abstract
Degeneration of substantia nigra (SN) dopaminergic (DAergic) neurons is responsible for the core motor deficits of Parkinson’s disease (PD). These neurons are autonomous pacemakers that have large cytosolic Ca2+ oscillations that have been linked to basal mitochondrial oxidant stress and turnover. This review explores the origin of Ca2+ oscillations and their role in the control of mitochondrial respiration, bioenergetics, and mitochondrial oxidant stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Effects of Ca2+ on mitochondrial bioenergetic metabolism and reactive oxygen species (ROS) production. The two primary sources of ATP in neurons are glycolysis and mitochondrial OXPHOS. During pacemaking, Ca2+ entry through Cav1 channels, coupled with CICR through RyRs, generates an elevation in [Ca2+]. Elevated [Ca2+] reaching the mitochondria favors the uptake of substrates by the mitochondria by acting on transporters and carriers on the IMM; Ca2+ taken up by mitochondria through the voltage-dependent anion channel (VDAC) and MCUC increases OXPHOS by enhancing the activity of the TCA cycle and by stimulating ATP synthesis by Complex V. The downside of this stimulation is an increase in the generation of ROS.](https://figures.cochat.ai/paper-figures/43417c2546714b5b8fd39a68f718f2a2/calcium-bioenergetics-and-parkinsons-disease-figure-2.jpg)
![Figure 3 Toxic effects of elevated [Ca2+] in SN DAergic neurons. The engagement of Cav1 channels in pacemaking and the release of Ca2+ through RyRs generate elevated cytosolic Ca2+ levels that increase α-synuclein (αSYN) aggregation, directly or through the activation of calpains; Ca2+-activated calpains can also damage several intracellular proteins. Ca2+ and calpain cleavage can increase or dysregulate tyrosine hydroxylase activity and DA production, and DA oxidation can favor the aggregation of αSYN.](https://figures.cochat.ai/paper-figures/f8532e4531ef46f7b8724d464c53bf55/calcium-bioenergetics-and-parkinsons-disease-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dopaminergic neurons are more vulnerable to the age-related loss of mitochondrial function, resulting in bioenergetic stress due to their highly ramified processes that harbour dense mitochondria to sustain energy-requiring processes at distal sites.188”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [188]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 404
Calpain in the CNS: From Synaptic Function to Neurotoxicity
Liu, J., Liu, M. C., & Wang, K. K. W. (2008) · Science Signaling · doi:10.1126/stke.114re1 · Cited by 196
Toward a redefinition of Parkinson's disease
Stern, M. B., Lang, A., & Poewe, W. (2012) · Movement Disorders · doi:10.1002/mds.24051 · Cited by 195
Ca2+ is a key factor in α-synuclein-induced neurotoxicity
Angelova, P. R., Ludtmann, M. H. R., Horrocks, M. H., Negoda, A., Cremades, N., Klenerman, D., Dobson, C. M., Wood, N. W., Pavlov, E. V., Gandhi, S., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.180737 · Cited by 194
RESPIRATORY ENZYMES IN OXIDATIVE PHOSPHORYLATION
Chance, B., & Williams, G. R. (1956) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65266-4 · Cited by 192
Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease
Sanders, L. H., McCoy, J., Hu, X., Mastroberardino, P. G., Dickinson, B. C., Chang, C. J., Chu, C. T., Van Houten, B., & Greenamyre, J. T. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.06.014 · Cited by 191
Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase
Ludtmann, M. H. R., Angelova, P. R., Ninkina, N. N., Gandhi, S., Buchman, V. L., & Abramov, A. Y. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1659-16.2016 · Cited by 189
Isradipine Versus Placebo in Early Parkinson Disease: A Randomized Trial
(2020) · Annals of Internal Medicine · doi:10.7326/m19-2534 · Cited by 189
Parkinson's Disease Is Not Simply a Prion Disorder
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1787-16.2017 · Cited by 188
Self-citationActivity of serotonin-containing neurons in the nucleus raphe pallidus of freely moving cats
Heym, J., Steinfels, G. F., & Jacobs, B. L. (1982) · Brain Research · doi:10.1016/0006-8993(82)90743-0 · Cited by 186
Mitochondrial oversight of cellular Ca2+ signaling
Babcock, D. F., & Hille, B. (1998) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(98)80067-6 · Cited by 186
Liang, C.-L., Wang, T. T., Luby-Phelps, K., & German, D. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.015 · Cited by 185
Choi, W.-S., Palmiter, R. D., & Xia, Z. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009132 · Cited by 183
Graves, S. M., Xie, Z., Stout, K. A., Zampese, E., Burbulla, L. F., Shih, J. C., Kondapalli, J., Patriarchi, T., Tian, L., Brichta, L., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-019-0556-3 · Cited by 183
Self-citationCelardo, I., Costa, A. C., Lehmann, S., Jones, C., Wood, N., Mencacci, N. E., Mallucci, G. R., Loh, S. H. Y., & Martins, L. M. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.173 · Cited by 182
The genetic architecture of mitochondrial dysfunction in Parkinson’s disease
Larsen, S. B., Hanss, Z., & Krüger, R. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2768-8 · Cited by 181
Genetics and genomics of Parkinson’s disease
Lin, M. K., & Farrer, M. J. (2014) · Genome Medicine · doi:10.1186/gm566 · Cited by 179
Physiological Roles of the Permeability Transition Pore
Brenner, C., & Moulin, M. (2012) · Circulation Research · doi:10.1161/circresaha.112.265942 · Cited by 178
Kostic, M., Ludtmann, M. H. R., Bading, H., Hershfinkel, M., Steer, E., Chu, C. T., Abramov, A. Y., & Sekler, I. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.079 · Cited by 177
Ca2+ Binding to α-Synuclein Regulates Ligand Binding and Oligomerization
Nielsen, M. S., Vorum, H., Lindersson, E., & Jensen, P. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101181200 · Cited by 176
Fu, Y., Yuan, Y., Halliday, G., Rusznák, Z., Watson, C., & Paxinos, G. (2012) · Brain Structure and Function · doi:10.1007/s00429-011-0349-2 · Cited by 176
Rinne, J. O., Ma, S. Y., Lee, M. S., Collan, Y., & Röyttä, M. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.01.006 · Cited by 175
Shepard, P. D., & Bunney, B. S. (1991) · Experimental Brain Research · doi:10.1007/bf00231048 · Cited by 174
Mitofusin 2 is necessary for striatal axonal projections of midbrain dopamine neurons
Lee, S., Sterky, F. H., Mourier, A., Terzioglu, M., Cullheim, S., Olson, L., & Larsson, N.-G. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds352 · Cited by 174
Mitochondrial oxidant stress in locus coeruleus is regulated by activity and nitric oxide synthase
Sanchez-Padilla, J., Guzman, J. N., Ilijic, E., Kondapalli, J., Galtieri, D. J., Yang, B., Schieber, S., Oertel, W., Wokosin, D., Schumacker, P. T., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3717 · Cited by 172
Self-citationExtrinsic Sources of Cholinergic Innervation of the Striatal Complex: A Whole-Brain Mapping Analysis
Dautan, D., Hacioğlu Bay, H., Bolam, J. P., Gerdjikov, T. V., & Mena-Segovia, J. (2016) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2016.00001 · Cited by 170
Parkinson's disease α-synuclein mutations exhibit defective axonal transport in cultured neurons
Saha, A. R., Hill, J., Utton, M. A., Asuni, A. A., Ackerley, S., Grierson, A. J., Miller, C. C., Davies, A. M., Buchman, V. L., Anderton, B. H., et al. (2004) · Journal of Cell Science · doi:10.1242/jcs.00967 · Cited by 169
NCLX: The mitochondrial sodium calcium exchanger
Boyman, L., Williams, G. S. B., Khananshvili, D., Sekler, I., & Lederer, W. J. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.03.012 · Cited by 169 · cited 1×
“Ca2+ is extruded from mitochondria by a Ca2+/H+ exchanger and—particularly in excitable cells—a Na+/Ca2+ exchanger (or Na+/Ca2+/Li2+ exchanger, NCLX) [25,42,43].”
BackgroundCalcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease
Goldberg, J. A., Guzman, J. N., Estep, C. M., Ilijic, E., Kondapalli, J., Sanchez-Padilla, J., & Surmeier, D. J. (2012) · Nature Neuroscience · doi:10.1038/nn.3209 · Cited by 167
Self-citationPham, A. H., Meng, S., Chu, Q. N., & Chan, D. C. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds311 · Cited by 166
Chu, N.-S., & Bloom, F. E. (1973) · Science · doi:10.1126/science.179.4076.908 · Cited by 165
The regulation of neuronal mitochondrial metabolism by calcium
Llorente‐Folch, I., Rueda, C. B., Pardo, B., Szabadkai, G., Duchen, M. R., & Satrustegui, J. (2015) · The Journal of Physiology · doi:10.1113/jp270254 · Cited by 165
Effects of Amphetamine on Single Cell Activity in a Catecholamine Nucleus, the Locus Coeruleus
GRAHAM, A. W., & AGHAJANIAN, G. K. (1971) · Nature · doi:10.1038/234100b0 · Cited by 165
Mitochondrial Ca2+ homeostasis: mechanism, role, and tissue specificities
Pizzo, P., Drago, I., Filadi, R., & Pozzan, T. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1122-y · Cited by 165 · cited 2×
“In healthy mitochondria, the electrochemical gradient across the IMM created by the electron transport chain (ETC) is very steep (~180 mV), providing a strong driving force for Ca2+ entry into the mitochondrial matrix [25,26].”
BackgroundLowe, R., Pountney, D. L., Jensen, P. H., Gai, W. P., & Voelcker, N. H. (2004) · Protein Science · doi:10.1110/ps.04879704 · Cited by 165
ER–mitochondria signaling in Parkinson’s disease
Gómez-Suaga, P., Bravo-San Pedro, J. M., González-Polo, R. A., Fuentes, J. M., & Niso-Santano, M. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0079-3 · Cited by 164
Substantia nigra and ventral tegmental area projections to cortex: Topography and collateralization
Loughlin, S. E., & Fallon, J. H. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90034-4 · Cited by 162
Tsunemi, T., Perez-Rosello, T., Ishiguro, Y., Yoroisaka, A., Jeon, S., Hamada, K., Rammonhan, M., Wong, Y. C., Xie, Z., Akamatsu, W., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.3085-18.2019 · Cited by 162
Self-citationDistinct cleavage patterns of normal and pathologic forms of α‐synuclein by calpain I in vitro
Mishizen‐Eberz, A. J., Guttmann, R. P., Giasson, B. I., Day, G. A., Hodara, R., Ischiropoulos, H., Lee, V. M. ‐., Trojanowski, J. Q., & Lynch, D. R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01878.x · Cited by 160
Generating bursts (and pauses) in the dopamine midbrain neurons
Paladini, C. A., & Roeper, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.032 · Cited by 160 · cited 2×
“The autonomous pacemaking of SN DAergic neurons is modulated up and down by synaptic inputs [77], allowing bidirectional control of DA release, which in turn bidirectionally modulate basal ganglia circuits [78–80].”
BackgroundA tale on animal models of Parkinson's disease
Bezard, E., & Przedborski, S. (2011) · Movement Disorders · doi:10.1002/mds.23696 · Cited by 159
The axonal arborization of single nigrostriatal neurons in rats
Gauthier, J., Parent, M., Lévesque, M., & Parent, A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01573-5 · Cited by 158
Apamin-sensitive Ca2+-activated K+ channels regulate pacemaker activity in nigral dopamine neurons
Ping, H. X., & Shepard, P. D. (1996) · NeuroReport · doi:10.1097/00001756-199602290-00031 · Cited by 156
Dopaminergic modulation of striatal networks in health and Parkinson's disease
Surmeier, D. J., Graves, S. M., & Shen, W. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.07.008 · Cited by 156
Self-citationRaised calcium promotes α-synuclein aggregate formation
Nath, S., Goodwin, J., Engelborghs, Y., & Pountney, D. L. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.12.004 · Cited by 154
Use of Calcium Channel Blockers and Parkinson’s Disease
Pasternak, B., Svanström, H., Nielsen, N. M., Fugger, L., Melbye, M., & Hviid, A. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr362 · Cited by 154
Zambon, F., Cherubini, M., Fernandes, H. J. R., Lang, C., Ryan, B. J., Volpato, V., Bengoa-Vergniory, N., Vingill, S., Attar, M., Booth, H. D. E., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz038 · Cited by 154
Electrophysiological properties of mouse dopamine neurons: In vivo and in vitro studies
Sanghera, M. K., Trulson, M. E., & German, D. C. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90171-4 · Cited by 153
Ekstrand, M. I., & Galter, D. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70811-9 · Cited by 151
Putzier, I., Kullmann, P. H. M., Horn, J. P., & Levitan, E. S. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4742-09.2009 · Cited by 148
Extracellular α-synuclein levels are regulated by neuronal activity
Yamada, K., & Iwatsubo, T. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0241-0 · Cited by 148
Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones
Mercuri, N. B., Bond, A., Calabresi, P., Stratta, F., Stefani, A., & Bernardi, G. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17068.x · Cited by 143 · cited 1×
“However, the opening of Cav1 channels is not necessary for pacemaking, as asserted previously based upon experiments that employed dihydropyridines (DHPs) at concentrations where channel specificity is lost [89,96].”
BackgroundGautier, C. A., Erpapazoglou, Z., Mouton-Liger, F., Muriel, M. P., Cormier, F., Bigou, S., Duffaure, S., Girard, M., Foret, B., Iannielli, A., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw148 · Cited by 140
Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress
Guzman, J. N., Ilijic, E., Yang, B., Sanchez-Padilla, J., Wokosin, D., Galtieri, D., Kondapalli, J., Schumacker, P. T., & Surmeier, D. J. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95898 · Cited by 135
Self-citationThe Parkinsonian Mimetic, MPP+, Specifically Impairs Mitochondrial Transport in Dopamine Axons
Kim-Han, J. S., Antenor-Dorsey, J. A., & O'Malley, K. L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0711-11.2011 · Cited by 133
Chen, B. T., & Rice, M. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07841.2001 · Cited by 129
Verma, M., Callio, J., Otero, P. A., Sekler, I., Wills, Z. P., & Chu, C. T. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3791-16.2017 · Cited by 128
Calcineurin determines toxic versus beneficial responses to α-synuclein
Caraveo, G., Auluck, P. K., Whitesell, L., Chung, C. Y., Baru, V., Mosharov, E. V., Yan, X., Ben-Johny, M., Soste, M., Picotti, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413201111 · Cited by 126
Alpha‐synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation
Betzer, C., Lassen, L. B., Olsen, A., Kofoed, R. H., Reimer, L., Gregersen, E., Zheng, J., Calì, T., Gai, W., Chen, T., et al. (2018) · EMBO reports · doi:10.15252/embr.201744617 · Cited by 125
Endogenous Calcium Buffering Capacity of Substantia Nigral Dopamine Neurons
Foehring, R. C., Zhang, X. F., Lee, J. C. F., & Callaway, J. C. (2009) · Journal of Neurophysiology · doi:10.1152/jn.00038.2009 · Cited by 123
Park, S. M., Jung, H. Y., Kim, T. D., Park, J. H., Yang, C.-H., & Kim, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111971200 · Cited by 123
Takakusaki, K., & Kitai, S. T. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00540-4 · Cited by 121
Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons
Dragicevic, E., Poetschke, C., Duda, J., Schlaudraff, F., Lammel, S., Schiemann, J., Fauler, M., Hetzel, A., Watanabe, M., Lujan, R., et al. (2014) · Brain · doi:10.1093/brain/awu131 · Cited by 121
Pickrell, A. M., Pinto, M., Hida, A., & Moraes, C. T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4871-11.2011 · Cited by 120
Calcium spike underlying rhythmic firing in dopaminergic neurons of the rat substantia nigra
Kang, Y., & Kitai, S. T. (1993) · Neuroscience Research · doi:10.1016/0168-0102(93)90055-u · Cited by 120
The Evolving Understanding of Dopamine Neurons in the Substantia Nigra and Ventral Tegmental Area
Gantz, S. C., Ford, C. P., Morikawa, H., & Williams, J. T. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021317-121615 · Cited by 120
Liss, B., & Striessnig, J. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021214 · Cited by 118
Physiological Phenotype and Vulnerability in Parkinson's Disease
Surmeier, D. J., Guzman, J. N., Sanchez, J., & Schumacker, P. T. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009290 · Cited by 117 · cited 1×
“OXPHOS complements glycolysis, generating 18 molecules of ATP for each pyruvate molecule produced from the metabolism of glucose [53,54].”
BackgroundSelf-citationToyofuku, T., Okamoto, Y., Ishikawa, T., Sasawatari, S., & Kumanogoh, A. (2019) · The EMBO Journal · doi:10.15252/embj.2018100875 · Cited by 117
Liang, C., Sinton, C. M., Sonsalla, P. K., & German, D. C. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0042 · Cited by 116
Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells
Smith, A. M., Depp, C., Ryan, B. J., Johnston, G. I., Alegre‐Abarrategui, J., Evetts, S., Rolinski, M., Baig, F., Ruffmann, C., Simon, A. K., et al. (2018) · Movement Disorders · doi:10.1002/mds.104 · Cited by 116
Diepenbroek, M., Casadei, N., Esmer, H., Saido, T. C., Takano, J., Kahle, P. J., Nixon, R. A., Rao, M. V., Melki, R., Pieri, L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu112 · Cited by 114
Huang, E., Qu, D., Huang, T., Rizzi, N., Boonying, W., Krolak, D., Ciana, P., Woulfe, J., Klein, C., Slack, R. S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01435-1 · Cited by 111
Kupsch, A. R., Sautter, J., Schwarz, J., Riederer, P. F., Gerlach, M., & Oertel, W. H. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00917-1 · Cited by 110
Prigent, A., Agid, Y., & Hirsch, É. C. (1994) · Brain Research · doi:10.1016/0006-8993(94)90511-8 · Cited by 107
Electrophysiological diversity of the dorsal raphe cells across the sleep–wake cycle of the rat
Urbain, N., Creamer, K., & Debonnel, G. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108514 · Cited by 107
Cav1 L‐type Ca2+ channel signaling complexes in neurons
Calin‐Jageman, I., & Lee, A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05286.x · Cited by 106
T-type calcium channels: From molecule to therapeutic opportunities
Weiss, N., & Zamponi, G. W. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.01.008 · Cited by 106
Antagonistic Pleiotropy in Human Disease
Byars, S., & Voskarides, K. (2019) · Journal of Molecular Evolution · doi:10.1007/s00239-019-09923-2 · Cited by 106
Roeper, J., & Ashcroft, F. M. (1995) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00373838 · Cited by 104
Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28k and calretinin
Liang, C., Sinton, C. M., & German, D. C. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00228-x · Cited by 104
α‐Synuclein modulation of Ca2+signaling in human neuroblastoma (SH‐SY5Y) cells
Hettiarachchi, N. T., Parker, A., Dallas, M. L., Pennington, K., Hung, C., Pearson, H. A., Boyle, J. P., Robinson, P., & Peers, C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06411.x · Cited by 104
Scarnati, E., Proia, A., Loreto, S. D., & Pacitti, C. (1987) · Brain Research · doi:10.1016/0006-8993(87)90831-6 · Cited by 104
Chen, R., Park, H., Mnatsakanyan, N., Niu, Y., Licznerski, P., Wu, J., Miranda, P., Graham, M. M., Tang, J., Boon, A. J. W., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1679-x · Cited by 103
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
Benkert, J., Heß, S., Roy, S., Beccano-Kelly, D. A., Burkert, N., Duda, J., Simons, C., Patil, K., Gaifullina, A., Mannal, N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12834-x · Cited by 103 · cited 2×
“3 channels protects mice from MPTP neurotoxicity [99].”
BackgroundHeo, J. Y., Park, J. H., Kim, S. J., Seo, K. S., Han, J. S., Lee, S. H., Kim, J. M., Park, J. I., Park, S. K., Lim, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032629 · Cited by 102
Evans, R. C., Zhu, M., & Khaliq, Z. M. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0117-17.2017 · Cited by 102
Ortner, N. J., Bock, G., Dougalis, A., Kharitonova, M. V., Duda, J., Heß, S., Tuluc, P., Pomberger, T., Stefanova, N., Pitterl, F., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2946-16.2017 · Cited by 101
Parkinson's Disease-associated α-Synuclein Is a Calmodulin Substrate
Martinez, J., Moeller, I., Erdjument-Bromage, H., Tempst, P., & Lauring, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209020200 · Cited by 100
Cellular and Synaptic Dysfunctions in Parkinson’s Disease: Stepping Out of the Striatum
Mallet, N. P., Delgado-Zabalza, L., Chazalon, M., Miguélez, C., & Baufreton, J. (2019) · Cells · doi:10.3390/cells8091005 · Cited by 100 · cited 1×
“This release is known to modulate synaptic input to neighboring substantia nigra pars reticulata (SNr) GABAergic neurons that form a major portion of the basal ganglia interface with the rest of the brain [84].”
BackgroundAntihypertensive Agents and Risk of Parkinson's Disease: A Nationwide Cohort Study
Lee, Y.-C., Lin, C.-H., Wu, R.-M., Lin, J.-W., Chang, C.-H., & Lai, M.-S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098961 · Cited by 99
Mitochondrial remodeling: Rearranging, recycling, and reprogramming
Gottlieb, R. A., & Bernstein, D. (2016) · Cell Calcium · doi:10.1016/j.ceca.2016.04.006 · Cited by 97
Pozo Devoto, V. M., Dimopoulos, N., Alloatti, M., Pardi, M. B., Saez, T. M., Otero, M. G., Cromberg, L. E., Marín-Burgin, A., Scassa, M. E., Stokin, G. B., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05334-9 · Cited by 97
Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease
Surmeier, D. J., Halliday, G. M., & Simuni, T. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.001 · Cited by 97 · cited 1×
“It’s our thesis that the vulnerability of SN DAergic neurons to aging and PD [85] is in large measure attributable to their distinctive phenotype [86].”
BackgroundSelf-citationGiaime, E., Yamaguchi, H., Gautier, C. A., Kitada, T., & Shen, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040501 · Cited by 95
Kim, S., Yun, H.-M., Baik, J.-H., Chung, K. C., Nah, S.-Y., & Rhim, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701418200 · Cited by 90
Tabata, Y., Imaizumi, Y., Sugawara, M., Andoh-Noda, T., Banno, S., Chai, M., Sone, T., Yamazaki, K., Ito, M., Tsukahara, K., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.09.006 · Cited by 90
Masuko, S., Nakajima, Y., Nakajima, S., & Yamaguchi, K. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-11-03229.1986 · Cited by 89
Inhibition of the mitochondrial calcium uniporter rescues dopaminergic neurons in pink1−/− zebrafish
Soman, S., Keatinge, M., Moein, M., Da Costa, M., Mortiboys, H., Skupin, A., Sugunan, S., Bazala, M., Kuznicki, J., & Bandmann, O. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13473 · Cited by 89
Giguère, N., Delignat-Lavaud, B., Herborg, F., Voisin, A., Li, Y., Jacquemet, V., Anand-Srivastava, M., Gether, U., Giros, B., & Trudeau, L.-É. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008352 · Cited by 89
Roles for the Endoplasmic Reticulum in Regulation of Neuronal Calcium Homeostasis
Karagas, N. E., & Venkatachalam, K. (2019) · Cells · doi:10.3390/cells8101232 · Cited by 89 · cited 1×
“The primary agonist of RyR is Ca2+ itself; thus, cytosolic Ca2+ transients can trigger Ca2+-induced Ca2+ release” (CICR) from the ER [12,13,18].”
BackgroundAre dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
Bisaglia, M., Filograna, R., Beltramini, M., & Bubacco, L. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2013.12.009 · Cited by 88
Sleep-waking discharge profiles of dorsal raphe nucleus neurons in mice
Sakai, K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.024 · Cited by 88
Kupsch, A. R., Gerlach, M., Pupeter, S. C., Sautter, J., Dirr, A., Arnold, G., Opitz, W., Przuntek, H., Riederer, P. F., & Oertel, W. H. (1995) · Neuroreport · doi:10.1097/00001756-199503000-00009 · Cited by 87
Post, M. R., Lieberman, O. J., & Mosharov, E. V. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00161 · Cited by 85
Scholze, A., Plant, T. D., Dolphin, A. C., & Nürnberg, B. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.7.0666 · Cited by 84
The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons
Lu, X., Kim‐Han, J. S., Harmon, S., Sakiyama‐Elbert, S. E., & O’Malley, K. L. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-17 · Cited by 84
Parkin functionally interacts with PGC-1α to preserve mitochondria and protect dopaminergic neuron s
Zheng, L., Bernard-Marissal, N., Moullan, N., D’Amico, D., Auwerx, J., Moore, D. J., Knott, G., Aebischer, P., & Schneider, B. L. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddw418 · Cited by 84
Ludtmann, M. H. R., Kostic, M., Horne, A., Gandhi, S., Sekler, I., & Abramov, A. Y. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1469-5 · Cited by 82
Sterky, F. H., Hoffman, A. F., Milenkovic, D., Bao, B., Paganelli, A., Edgar, D., Wibom, R., Lupica, C. R., Olson, L., & Larsson, N.-G. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr537 · Cited by 77
The importance of preclinical diagnostics in Parkinson disease
Mantri, S., Morley, J. F., & Siderowf, A. D. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.09.011 · Cited by 77
Alreja, M., & Aghajanian, G. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90327-r · Cited by 76
Calcium-Triggered Membrane Interaction of the α-Synuclein Acidic Tail
Tamamizu‐Kato, S., Kosaraju, M. G., Kato, H., Raussens, V., Ruysschaert, J., & Narayanaswami, V. (2006) · Biochemistry · doi:10.1021/bi060939i · Cited by 76
Asanuma, M., Miyazaki, I., Diaz-Corrales, F. J. J., & Ogawa, N. (2004) · PubMed · doi:10.18926/amo/32105 · Cited by 76
Penna, E., Espino, J., Stefani, D. D., & Rizzuto, R. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.08.008 · Cited by 75 · cited 1×
“The MCUC is composed of the channel-forming unit, known as the mitochondrial Ca2+ uniporter (MCU) [27,28], and several accessory proteins that influence MCU gating [29,30].”
BackgroundPienaar, I. S., Elson, J. L., Racca, C., Nelson, G., Turnbull, D. M., & Morris, C. M. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.09.002 · Cited by 74
Choi, Y. M., Kim, S. H., Chung, S., Uhm, D. Y., & Park, M. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3158-06.2006 · Cited by 73
Gaspar, P., Jelloun, N. B., & Febvret, A. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90232-1 · Cited by 73
Zampese, E., & Pizzo, P. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0845-9 · Cited by 73
Self-citationDíaz-Vegas, A. R., Cordova, A., Valladares, D., Llanos, P., Hidalgo, C., Gherardi, G., De Stefani, D., Mammucari, C., Rizzuto, R., Contreras-Ferrat, A., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00791 · Cited by 71
Soman, S. K., Bazała, M., Keatinge, M., Bandmann, O., & Kuznicki, J. (2019) · Biology Open · doi:10.1242/bio.044347 · Cited by 70
Differential Somatic Ca2+ Channel Profile in Midbrain Dopaminergic Neurons
Philippart, F., Destreel, G., Merino-Sepulveda, P., Henny, P., Engel, D., & Seutin, V. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0459-16.2016 · Cited by 69 · cited 1×
“In contrast, VTA DAergic neurons are pacemakers, but do not manifest large [Ca2+] transients and are largely spared in PD [97,105,122,176].”
BackgroundLieberman, O. J., Choi, S. J., Kanter, E., Saverchenko, A., Frier, M. D., Fiore, G. M., Wu, M., Kondapalli, J., Zampese, E., Surmeier, D. J., et al. (2017) · eneuro · doi:10.1523/eneuro.0167-17.2017 · Cited by 69
Self-citationHan, J. Y., Choi, T. S., & Kim, H. I. (2018) · Scientific Reports · doi:10.1038/s41598-018-20320-5 · Cited by 67
Evidence for regulation of mitochondrial function by the L-type Ca2+ channel in ventricular myocytes
Viola, H. M., Arthur, P. G., & Hool, L. C. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.12.015 · Cited by 66
Teves, J. M. Y., Bhargava, V., Kirwan, K. R., Corenblum, M. J., Justiniano, R., Wondrak, G. T., Anandhan, A., Flores, A. J., Schipper, D. A., Khalpey, Z., et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00737 · Cited by 66
Greene, J. G. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5859 · Cited by 65
Dihydropyridine calcium channel blockers and the progression of parkinsonism
Marras, C., Gruneir, A., Rochon, P. A., Wang, X., Anderson, G., Brotchie, J. M., Bell, C. M., Fox, S. H., & Austin, P. C. (2011) · Annals of Neurology · doi:10.1002/ana.22616 · Cited by 65
Hainsworth, A. H., Röper, J., Kapoor, R., & Ashcroft, F. M. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90419-o · Cited by 65
Cytosolic Calcium Coordinates Mitochondrial Energy Metabolism with Presynaptic Activity
Chouhan, A. K., Ivannikov, M. V., Lu, Z., Sugimori, M., Llinas, R. R., & Macleod, G. T. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1301-11.2012 · Cited by 65
Hage, T. A., & Khaliq, Z. M. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3904-14.2015 · Cited by 64
Mitochondria as regulators of stimulus-evoked calcium signals in neurons
Friel, D. D. (2000) · Cell Calcium · doi:10.1054/ceca.2000.0172 · Cited by 64
Singh, A., Verma, P., Balaji, G., Samantaray, S., & Mohanakumar, K. P. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.07.003 · Cited by 64
Cytosolic, but not matrix, calcium is essential for adjustment of mitochondrial pyruvate supply
Szibor, M., Gizatullina, Z. Z., Gainutdinov, T. M., Endres, T., Dębska–Vielhaber, G., Kunz, M., Karavasili, N., Hallmann, K., Schreiber, F., Bamberger, A., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011902 · Cited by 64 · cited 1×
“IMS Ca2+ stimulates the transport of metabolites into the matrix [59,61].”
BackgroundRoš, H., Magill, P. J., Moss, J., Bolam, J. P., & Mena-Segovia, J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.068 · Cited by 63
Fujimura, K., & Matsuda, Y. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90328-5 · Cited by 61
Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease
Ambrosi, G., Ghezzi, C., Sepe, S., Milanese, C., Payán‐Gómez, C., Bombardieri, C. R., Armentero, M., Zangaglia, R., Pacchetti, C., Mastroberardino, P. G., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.008 · Cited by 61
Dufour, M. A., Woodhouse, A., & Goaillard, J. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23382 · Cited by 61
The control of brain mitochondrial energization by cytosolic calcium: The mitochondrial gas pedal
Gellerich, F. N., Gizatullina, Z., Gainutdinov, T., Muth, K., Seppet, E., Orynbayeva, Z., & Vielhaber, S. (2013) · IUBMB Life · doi:10.1002/iub.1131 · Cited by 59 · cited 1×
“IMS Ca2+ stimulates the transport of metabolites into the matrix [59,61].”
BackgroundPotassium Depolarization and Raised Calcium Induces α-Synuclein Aggregates
Follett, J., Darlow, B., Wong, M. B., Goodwin, J., & Pountney, D. L. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9366-z · Cited by 57
The Endoplasmic Reticulum as an Integrator of Multiple Dendritic Events
Park, M. K., Choi, Y. M., Kang, Y. K., & Petersen, O. H. (2007) · The Neuroscientist · doi:10.1177/1073858407305691 · Cited by 57
Dysregulated Interorganellar Crosstalk of Mitochondria in the Pathogenesis of Parkinson’s Disease
Sironi, L., Restelli, L. M., Tolnay, M., Neutzner, A., & Frank, S. (2020) · Cells · doi:10.3390/cells9010233 · Cited by 57
Aumann, T. D., Egan, K., Lim, J., Boon, W. C., Bye, C. R., Chua, H. K., Baban, N., Parish, C. L., Bobrovskaya, L., Dickson, P., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07151.x · Cited by 56
From dysfunctional endoplasmic reticulum-mitochondria coupling to neurodegeneration
Erpapazoglou, Z., Mouton-Liger, F., & Corti, O. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.03.021 · Cited by 56
Wang, Q., Xu, Y., Liu, S., & Ma, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.17618 · Cited by 55
Targeting mitochondrial calcium pathways as a potential treatment against Parkinson’s disease
Dey, K., Bazała, M. A., & Kuźnicki, J. (2020) · Cell Calcium · doi:10.1016/j.ceca.2020.102216 · Cited by 55
Nichols, M. T., Elustondo, P. A., Warford, J. R., Thirumaran, A., Pavlov, E. V., & Robertson, G. S. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16682250 · Cited by 54 · cited 1×
“Ablating the MCU and preventing Ca2+ uptake in mitochondria leads to a compensatory upregulation of glycolysis, supporting the critical role of OXPHOS and its stimulation by Ca2+ for neuronal health [70].”
BackgroundEmerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness
Cieri, D., Brini, M., & Calí, T. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.153 · Cited by 53
López-Fabuel, I., Martin-Martin, L., Resch-Beusher, M., Azkona, G., Sánchez‐Pernaute, R., & Bolaños, J. P. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.03.023 · Cited by 53
Parkin-dependent regulation of the MCU complex component MICU1
Matteucci, A., Patrón, M., Reane, D. V., Gastaldello, S., Amoroso, S., Rizzuto, R., Brini, M., Raffaello, A., & Calí, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-32551-7 · Cited by 53
Choi, W., Kim, H.-W., Tronche, F., Palmiter, R. D., Storm, D. R., & Xia, Z. (2017) · Scientific Reports · doi:10.1038/srep44989 · Cited by 52
The pedunclopontine nucleus and Parkinson's disease
Tubert, C., Galtieri, D., & Surmeier, D. J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.017 · Cited by 52
Self-citationTakada, M., Kang, Y., & Imanishi, M. (2001) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2001.01435.x · Cited by 51
Elstner, M., Müller, S. K., Leidolt, L., Laub, C., Krieg, L., Schlaudraff, F., Liss, B., Morris, C., Turnbull, D. M., Masliah, E., et al. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-43 · Cited by 50
Dukes, A. A., Bai, Q., Van Laar, V. S., Zhou, Y., Ilin, V., David, C. N., Agim, Z. S., Bonkowsky, J. L., Cannon, J. R., Watkins, S. C., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.020 · Cited by 50
Calí, T., Ottolini, D., Vicario, M., Catoni, C., Vallese, F., Cieri, D., Barazzuol, L., & Brini, M. (2019) · Cells · doi:10.3390/cells8091072 · Cited by 50
Galtieri, D. J., Estep, C. M., Wokosin, D. L., Traynelis, S. F., & Surmeier, D. J. (2017) · eLife · doi:10.7554/elife.30352 · Cited by 49
Self-citationParkinson's disease: Is it a consequence of human brain evolution?
Diederich, N. J., Surmeier, D. J., Uchihara, T., Grillner, S., & Goetz, C. G. (2019) · Movement Disorders · doi:10.1002/mds.27628 · Cited by 49
Self-citationPetzold, A., Valencia, M., Pál, B., & Mena-Segovia, J. (2015) · Frontiers in Neural Circuits · doi:10.3389/fncir.2015.00068 · Cited by 47
Lewy body pathology is associated with mitochondrial DNA damage in Parkinson's disease
Müller, S. K., Bender, A., Laub, C., Högen, T., Schlaudraff, F., Liss, B., Klopstock, T., & Elstner, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.016 · Cited by 47
Parkinson disease: an evolutionary perspective.
Garcia-Ruiz, P. J., & Espay, A. J. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00157 · Cited by 46
Calí, T., Ottolini, D., Soriano, M. E., & Brini, M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu519 · Cited by 45
Zahid, M., SAEED, M. K., Yang, L., Beseler, C. L., Rogan, E. G., & Cavalieri, E. L. (2011) · IUBMB Life · doi:10.1002/iub.538 · Cited by 44
Calretinin-containing axons and neurons are resistant to an intrastriatal 6-hydroxydopamine lesion
Tsuboi, K., Kimber, T. A., & Shults, C. W. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02219-8 · Cited by 44
Rcom-H'cheo-Gauthier, A. N., Meedeniya, A. C. B., & Pountney, D. L. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13971 · Cited by 44
Parrado‐Fernández, C., Schreiner, B., Ankarcrona, M., Conti, M. M., Cookson, M. R., Kivipelto, M., Cedazo-Mínguez, Á., & Matton, A. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13815 · Cited by 44
Kim, H.-W., Choi, W.-S., Sorscher, N., Park, H. J., Tronche, F., Palmiter, R. D., & Xia, Z. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.05.008 · Cited by 43
Trulson, M. E., & Frederickson, C. J. (1987) · Brain Research Bulletin · doi:10.1016/0361-9230(87)90189-4 · Cited by 43
Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease
Buchman, A. S., Nag, S., Shulman, J. M., Lim, A. S. P., VanderHorst, V., Leurgans, S. E., Schneider, J. A., & Bennett, D. A. (2012) · Movement Disorders · doi:10.1002/mds.25142 · Cited by 43
Nifedipine blocks apamin-induced bursting activity in nigral dopamine-containing neurons
Shepard, P. D., & Stump, D. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01231-1 · Cited by 43
Comparison of projections of the dorsal and median raphe nuclei, with some functional considerations
Vertes, R. P., & Linley, S. B. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.046 · Cited by 43
Preserve and protect: maintaining axons within functional circuits
Pease-Raissi, S. E., & Segal, R. A. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.07.007 · Cited by 43
Hoťka, M., Cagalinec, M., Hilber, K., Hool, L. C., Boehm, S., & Kubista, H. (2020) · Science Signaling · doi:10.1126/scisignal.aaw6923 · Cited by 43
Electrophysiological Characteristics of Dopamine Neurons: A 35-Year Update
Shi, W. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_8 · Cited by 41
Iyer, R., Ungless, M. A., & Faisal, A. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-05578-5 · Cited by 41
A concerted action of L- and T-type Ca2+ channels regulates locus coeruleus pacemaking
Matschke, L. A., Bertoune, M., Roeper, J., Snutch, T. P., Oertel, W. H., Rinné, S., & Decher, N. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.08.012 · Cited by 40
Crunelli, V., & Segal, M. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90122-8 · Cited by 40
Mo, Z. L., Katafuchi, T., Muratani, H., & Hori, T. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019434 · Cited by 40
Mitochondrial Ca2+ signalling in hippocampal neurons
Young, K. W., Bampton, E. T. W., Piñon, L., Bano, D., & Nicotera, P. (2007) · Cell Calcium · doi:10.1016/j.ceca.2007.06.007 · Cited by 39
Activity‐dependent regulation of the dopamine phenotype in substantia nigra neurons
Aumann, T. D., & Horne, M. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07703.x · Cited by 37
Giguère, N., Pacelli, C., Saumure, C., Bourque, M.-J., Matheoud, D., Levesque, D., Slack, R. S., Park, D. S., & Trudeau, L.-É. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000499 · Cited by 37
Adenosine-induced inhibition of vagal motoneuron excitability: receptor subtype and mechanisms
Marks, J. D., Donnelly, D. F., & Haddad, G. G. (1993) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1993.264.2.l124 · Cited by 36
Deus, C. M., Pereira, S. P., Cunha-Oliveira, T., Pereira, F. B., Raimundo, N., & Oliveira, P. J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165615 · Cited by 36
Menezes, A., Zeman, R. J., & Sabban, E. L. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67062316.x · Cited by 34
Trulson, M. E., Crisp, T., & Trulson, V. M. (1984) · Experimental Brain Research · doi:10.1007/bf00235816 · Cited by 34
Mak, S. K., Tewari, D., Tetrud, J. W., Langston, J. W., & Schüle, B. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11025 · Cited by 34
Progressive Degeneration of Dopaminergic Neurons through TRP Channel-Induced Cell Death
Nagarajan, A., Ning, Y., Reisner, K., Buraei, Z., Larsen, J. P., Hobert, O., & Doitsidou, M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4540-13.2014 · Cited by 33
Lasser-Katz, E., Simchovitz, A., Chiu, W., Oertel, W. H., Sharon, R., Soreq, H., Roeper, J., & Goldberg, J. A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1079-16.2016 · Cited by 33
van der Merwe, C., Loos, B., Swart, C., Kinnear, C. J., Henning, F., van der Merwe, L., Pillay, K., Muller, N., Zaharie, D., Engelbrecht, L., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.151 · Cited by 31
Pienaar, I. S., Vernon, A. C., & Winn, P. (2016) · The Neuroscientist · doi:10.1177/1073858416682471 · Cited by 31
Marinelli, S., Bernardi, G., Giacomini, P., & Mercuri, N. B. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00186-0 · Cited by 30
Knockdown of the mitochondria‐localized protein p13 protects against experimental parkinsonism
Inoue, N., Ogura, S., Kasai, A., Nakazawa, T., Ikeda, K., Higashi, S., Isotani, A., Baba, K., Mochizuki, H., Fujimura, H., et al. (2018) · EMBO Reports · doi:10.15252/embr.201744860 · Cited by 30
Yee, A. G., Forbes, B., Cheung, P., Martini, A., Burrell, M., Freestone, P. S., & Lipski, J. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14587 · Cited by 30
de Vrind, V. A. J., Scuvée‐Moreau, J., Drion, G., Hmaied, C., Philippart, F., Engel, D., & Seutin, V. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.046 · Cited by 28
Imber, A. N., & Putnam, R. W. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01585.2011 · Cited by 27
Serotonin neurons and their physiological roles.
Maeda, T., Fujimiya, M., Kitahama, K., Imai, H., & Kimura, H. (1989) · Archivum histologicum japonicum · doi:10.1679/aohc.52.suppl_113 · Cited by 26
Modulation of human α-synuclein aggregation by a combined effect of calcium and dopamine
Jain, M. K., & Bhat, R. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.004 · Cited by 25
Mironov, S. L. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.280974 · Cited by 24
Moon, H. E., Yoon, S. H., Hur, Y. S., Park, H. W., Ha, J. Y., Kim, K., Shim, J. H., Yoo, S. H., Son, J. H., Paek, S. L., et al. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.4.283 · Cited by 24
Asaoka, N., Nishitani, N., Kinoshita, H., Kawai, H., Shibui, N., Nagayasu, K., Shirakawa, H., Nakagawa, T., & Kaneko, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-13599-3 · Cited by 23
L-Type Cav1.2 Calcium Channel is Involved in 6-Hydroxydopamine-Induced Neurotoxicity in Rats
Wang, R., Ma, Z., Wang, J., & Xie, J. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9271-x · Cited by 20
Research works printed but not linked: 1
- Rizzuto, 2004, Flirting in little space: The ER/mitochondria Ca2+ liaison, Sci. STKE Signal Transduct. Knowl. Environ., 2004, re1
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Mitochondrial Ca2+ Signaling in Health, Disease and Therapy
Modesti, L., Danese, A., Vitto, V. A. M., Ramaccini, D., Aguiari, G., Gafà, R., Lanza, G., Giorgi, C., & Pinton, P. (2021) · Cells · doi:10.3390/cells10061317 · Cited by 130
“Neuronal Ca2+ regulation is extremely important even before the appearance of the pathological characteristics of these diseases [99,102,103].”
BackgroundMachine learning and digital biomarkers can detect early stages of neurodegenerative diseases
Chudzik, A., Śledzianowski, A., & Przybyszewski, A. W. (2024) · Sensors · doi:10.3390/s24051572 · Cited by 122
Ca 2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons
Zampese, E., Wokosin, D. L., González‐Rodríguez, P., Guzmán, J. N., Tkatch, T., Kondapalli, J., Surmeier, W. C., D’Alessandro, K. B., Stefani, D. D., Rizzuto, R., et al. (2022) · Science Advances · doi:10.1126/sciadv.abp8701 · Cited by 104
“Ca 2+ release by the ER can affect mitochondrial OXPHOS in two ways ( 14 , 43 ).”
InfluentialSelf-citationUnraveling Parkinson’s Disease Neurodegeneration: Does Aging Hold the Clues?
Coleman, C., & Martin, I. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223363 · Cited by 76
“Additionally, dopaminergic neurons may be more vulnerable to age-related loss of mitochondrial function and resulting bioenergetic stress due to their highly ramified processes that harbor dense mitochondria to sustain energy-requiring processes at distal sites [22].”
Background
Metadata
- Authors
- Zampese, E., & Surmeier, D. J.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Surmeier, D. James
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-09-08
- Volume
- 9
- Issue
- 9
- Pages
- 2045
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7564460
- OpenAlex
- W3083790931
- Cited by
- 79
- References
- 407
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 13 · 2023: 13 · 2022: 14 · 2021: 15 · 2020: 1
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Neurological Disorders and Stroke (P50NS047085)
- Michael J. Fox Foundation for Parkinson's Research (Surmeier)
- JPB Foundation (Surmeier)
- IDP Foundation (Surmeier)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, calcium oscillations, substantia nigra, dopaminergic neurons, mitochondrial respiration, bioenergetics, neurodegeneration, motor impairment
- MeSH terms
- Calcium, Energy Metabolism, Humans, Parkinson Disease, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.